8/6/2019 Barbeque Factory 22072011
1/1
OU BangaloreMirror | FRIDAY, JULY 22, 2011
2www.bangaloremirror.com/you
With a sub-Rs 500 all-you-
can-eat offering, a pleas-ant ambience, and a playarea for kids,
BarbequeFactory has some ele-
s in place to make it a decentrant. But when it comes to thethey
need to better their act.
SIS: Barbeque Factory is theenture of Leena Restaurants &s
Pvt Ltd, and its managementhas decades of experience inospitality
industry. The restau-tarted operations just over ah ago.
ATURE DISH: Shikkampurib, Dal Barbeque
: The prix fixe (set menu) has
the vegetarian version priced at`399 and the non vegetarian
at`499, both inclusive of tax,and introductory. While thismight
seem value-for-moneyconsidering the number of itemsserved, the
quality aspect calls fora sprucing up.
PARKING: Basement Parking
ALCOHOL: Only in the form ofwine.
VENUE: Barbeque Factory, Lotus 612/1,80 feet Road, 4th Block,
Koramangala,
Bangalore 560034, 41505325
FOODIES'FEEDBACK
Barbequeue: My dinner companions
were Selvaprakash, an entrepreneur,Monika Manchanda, prolific
food blog-ger, her husband Narendranath, who
works with Dell, and their son, Ojas.
Factory Floor: The factory makes anappearance only in the name,
and there
is no specific theme to the restaurant.The interiors manage to
exude warmththough, and you could enjoy a view of
the busy 80 feet Road below.
Factorisation: The menu begins with a
veg shorba and fresh fruits, and quicklymoves into a collection
of kababs fiveeach in veg and non veg. Chaas isserved throughout
the meal and before
we enter the main course, there is aHoney Paratha interlude. The
maincourse consists of rotis, a selection of
veg curries and a non veg curry and achoice of veg/chicken
biriyani. Themeal ends with a collection of threedesserts, Badam
Milk and a Maghai
Paan. The selection of kababs varies on
a daily basis.
X factor: We began well with the Creamof Tomato soup, mildly
spicy andflavourful. The boneless Fish Tikka,
though not Zaffrani as indicated in themenu, was cooked to
perfection, andthe groups favourite starter. The Mut-ton Seekh,
again not part of the days
menu, but seemingly a replacement forthe Boti Kabab, was a close
second. TheChaas kept us good company through-
out the meal. The Honey Paratha wasappreciated for a well
managed sweet-salt combination. Though commonlyfound fare, the
Gulab Jamun, Semiya
Kheer and even the Badam Milk en-sured that the desserts section
was wellrepresented. The meal ended well with
slices of mango presented, for a
change, in a cocktail glass and amaghai paan.
Vex Factor: The Shikampuri kababslacked the slightly crispy
exterior,though the mutton version was slightlbetter than its veg
counterpart. The
Murg Tikkas were also not the bestweve had. The obvious
indicator of thkababs quality was that, despite the
unlimited offering, only the fish tikkaand the mutton seekh made
it to thesecond round of kabab consumption.the main course, neither
the Aloo Mut
ter nor the Dal Tadka showed any inclnation to enliven the meal.
The Biriyawas totally ignored as it was quite dry
and lacking in masala too.
Service: Friendly staff, but they were
quite clueless about what they wereserving. They also needed a
couple ofreminders for getting us a kabab refilAjay, part of the
management team,
could be seen going to every table and
courteously soliciting feedback. Heeven convinced Ojas, who
usually doe
nt consume orange juice at home, tohave a (complimentary) glass,
and warewarded with an It was nice.
Verdict: Barbeque Factory does have few things going for it, but
the locatiohas no dearth of gastronomic choices
The restaurant needs to focus more othe food if they want to
ensure that peple baar baar barbeque.
From left: Monika Manchanda, Ojas, Narendranath and
Selvaprakash
Not satisfactory yet
u [email protected]
THEPANRBEQUE FACTORY
FOODAMBIENCE
SERVICE
Bangalore Mirror revieanonymously and pays for me
FAHEEM HUSSAIN
CER drug currently in advanced clin-
als was found to alleviate symptomszophrenia in mice, according
to audy. Schizophrenia is one of the
ommon serious mental health con-s and affects about 24 million
peo-rldwide. The illness is a long-terml health condition that
causes a
er of psychological symptoms, in-g hallucinations and delusions
as behaviour changes. The new study
vealed the molecular pathway thatcted during the onset of
schizophre-or the first time we have found that
yme activator called p35 is reducedents with schizophrenia and
more-
modelling this reduction in mice lednitive impairment typical
for this dis-
ease," said Professor Peter Giese at
King's College London, who led the study."This gives us a better
understanding ofthe changes that occur in the brain during
the onset of schizophrenia."We noted that the reduction in p35
af-fects the same molecular changes target-ed by a cancer drug
called MS-275, so we
administered this drug to the mice."We were excited to find that
MS-275 notonly addressed the molecular changes but
also alleviated the symptoms associatedwith schizophrenia. "Our
findings encour-age the future exploration of these types
of drugs for treating impaired cognition inschizophrenia," he
added.The study has been published online in thejournal Brain.
ANI
THE2-MINUTEREAD
CER DRUGS MAY HELP TREAT SCHIZOPHRENIA
ELECTRONIC CIGARETTES are in reality
crude drug delivery systems for refinednicotine, posing unknown
risks with littlenew benefits to smokers, according to to-
bacco control experts.E-cigarettes are constructed to mimicreal
cigarettes in size and appearance,but contain no tobacco and are
not ciga-
rettes at all. In reality they are deliverydevices for refined
nicotine. The U.S.Food and Drug Administration had said
that it would regulate e-cigarettes as "to-bacco products" and
not as "drug-deliv-ery devices." That action came after fed-
eral courts blocked the agency from reg-ulating the products as
drug-delivery de-vices."The court's decision that e-cigarettes
should be regulated as tobacco prod
and not as drug-delivery devices hasstantially delayed the FDA
regulatoryprocess that normally protects the p
health. It has the practical effect of aing manufacturers to
sell potentiallygerous refined nicotine products direto consumers,"
said co-author Natha
Cobb, MD, a pulmonologist and assisprofessor at Georgetown
University Mical Center.
The authors argue that a comprehenapproach to regulating
products coning refined nicotine is needed to prot
the public's health and should involvCongress, the courts and
the FDA.The study was recently published in tNew England Journal of
Medicine.
E-CIGARETTES JUST DANGEROUS NICOTINE DRUG DELIVERY DEVICES
